Protective effects of inhibitors of nitric oxide synthase in immune complex‐induced vasculitis
Authors:
Open Access
- 1 December 1992
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 107 (4) , 1159-1162
Abstract
The ability of analogues of l‐arginine (N‐iminoethyl‐l‐ornithine (l‐NIO), NG‐monomethyl‐l‐arginine (l‐NMMA), NG‐nitro‐l‐arginine methyl ester (l‐NAME) and NG‐nitro‐l‐arginine (l‐NNA)) to protect against inflammatory injury induced by activated neutrophils was investigated in rats following intradermal or intrapulmonary deposition of immune complexes. The descending order of potency for protective effects of these analogues was: l‐NIO > l‐NMMA > l‐NNA = l‐NAME. The approximate IC50 value for l‐NIO in the dermal vasculitis model was 65 μm. For all other compounds, the IC50 values were > 5 mm. The protective effect of l‐NIO in the skin was reversed in a dose‐dependent manner by the presence of l‐arginine, but not by d‐arginine. l‐Arginine also reversed the protective effects of l‐NIO in immune complex‐induced lung injury. The protective effects of l‐NIO were not associated with reductions in neutrophil accumulation, as measured by extraction from tissues of myeloperoxidase. These data demonstrate that l‐NIO has the most potent protective effects against immune complex‐induced vascular injury induced by activated macrophages. Furthermore, they indicate that this injury is dependent upon the generation of nitric oxide.Keywords
This publication has 18 references indexed in Scilit:
- Multiple Cytokines Are Required to Induce Hepatocyte Nitric Oxide Production and Inhibit Total Protein SynthesisAnnals of Surgery, 1990
- Role of O2− in neutrophil recruitment into sites of dermal and pulmonary vasculitisFree Radical Biology and Medicine, 1990
- Non-enzymic activation of the fifth component of human complement, by oxygen radicals. Some properties of the activation product, C5b-like C5Molecular Immunology, 1989
- Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells.Journal of Experimental Medicine, 1989
- Formation and release of nitric oxide from human neutrophils and HL‐60 cells induced by a chemotactic peptide, platelet activating factor and leukotriene B4FEBS Letters, 1989
- Nitric oxide: A cytotoxic activated macrophage effector moleculeBiochemical and Biophysical Research Communications, 1988
- Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediateBiochemistry, 1988
- Generation of an activated form of human C5 (C5b-like C5) by oxygen radicalsImmunology Letters, 1987
- Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. Inhibition involves the iron-sulfur prosthetic group and is reversible.Journal of Clinical Investigation, 1986
- Acute Immunologic Pulmonary AlveolitisJournal of Clinical Investigation, 1974